525
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine

, , , , , , & show all
Pages 10435-10451 | Published online: 23 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eun A Kim, Jun Soo Park, Min Seop Kim, Min Young Jeong, Hyun Jin Park, Jun Hyuk Choi, Jae Hee Seo, Yong Seok Choi & Myung Joo Kang. (2021) High-Payload Nanosuspension of Centella asiatica Extract for Improved Skin Delivery with No Irritation. International Journal of Nanomedicine 16, pages 7417-7432.
Read now

Articles from other publishers (14)

D. Gomes, J.P. Batista-Silva, A. Sousa & L.A. Passarinha. (2023) Progress and opportunities in Gellan gum-based materials: A review of preparation, characterization and emerging applications. Carbohydrate Polymers 311, pages 120782.
Crossref
Preeti Dali & Pravin Shende. (2023) Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine. International Journal of Pharmaceutics 635, pages 122714.
Crossref
Asha Rani, Ravinder Verma, Vineet Mittal, Shailendra Bhatt, Manish Kumar, Abhishek Tiwari, Varsha Tiwari, Parijat Pandey & Deepak Kaushik. (2023) Formulation Development and Optimization of Rosuvastatin Loaded Nanosuspension for Enhancing Dissolution Rate. Current Drug Therapy 18:1, pages 75-87.
Crossref
Hongping Hou, Yujie Li, Ziying Xu, Zihui Yu, Bo Peng, Caixia Wang, Wei Liu, Wei Li, Zuguang Ye & Guangping Zhang. (2023) Applications and research progress of Traditional Chinese medicine delivered via nasal administration. Biomedicine & Pharmacotherapy 157, pages 113933.
Crossref
Cinzia Pagano, Luana Perioli & Maurizio Ricci. 2023. Nasal Drug Delivery. Nasal Drug Delivery 235 252 .
María L. Formica, Daniel A. Real, Matías L. Picchio, Elise Catlin, Ryan F. Donnelly & Alejandro J. Paredes. (2022) On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 29, pages 101631.
Crossref
K. Mohananaidu, Bappaditya Chatterjee, Farahidah Mohamed, Syed Mahmood & Samah Hamed Almurisi. (2022) Thermoreversible Carbamazepine In Situ Gel for Intranasal Delivery: Development and In Vitro, Ex Vivo Evaluation. AAPS PharmSciTech 23:8.
Crossref
Zhiyu Jin, Yu Han, Danshen Zhang, Zhongqiu Li, Yongshuai Jing, Beibei Hu & Shiguo Sun. (2022) Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 14:10, pages 2070.
Crossref
Laura Nižić Nodilo, Mirna Perkušić, Ivo Ugrina, Drago Špoljarić, Cvijeta Jakobušić Brala, Daniela Amidžić Klarić, Jasmina Lovrić, Vesna Saršon, Maša Safundžić Kučuk, Dijana Zadravec, Livije Kalogjera, Ivan Pepić & Anita Hafner. (2022) In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. European Journal of Pharmaceutics and Biopharmaceutics 175, pages 27-42.
Crossref
Chang Yang, Qing Zhao, Shanshan Yang, Libin Wang, Xingyuan Xu, Lisu Li & Wafa T. Al-Jamal. (2022) Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia–Reperfusion Injury in Rats. Molecular Pharmaceutics 19:5, pages 1410-1421.
Crossref
Shruti U. Rawal, Bhoomika M. Patel & Mayur M. Patel. (2022) New Drug Delivery Systems Developed for Brain Targeting. Drugs 82:7, pages 749-792.
Crossref
Deepika Joshi & Bhavna. (2022) Optimization of Chitosan-wrapped Linagliptin Nanosuspension for Cognitive Enhancement Through Intranasal Route. Nanoscience & Nanotechnology-Asia 12:2.
Crossref
E. O. Bakhrushina, N. B. Demina, M. M. Shumkova, P. S. Rodyuk, D. S. Shulikina & I. I. Krasnyuk. (2021) <i>In situ</i> Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review). Drug development & registration 10:4, pages 54-63.
Crossref
Hamdy Abdelkader, Zeinab Fathalla, Ali Seyfoddin, Mojtaba Farahani, Thilini Thrimawithana, Ayman Allahham, Adam W.G. Alani, Ali A. Al-Kinani & Raid G. Alany. (2021) Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Advanced Drug Delivery Reviews 177, pages 113957.
Crossref